The place of ropivacaine in modern regional anesthesia

Literature:

1. Aberg, (1972). Toxicological and local anesthetic effects of optically active isomers of two local anesthetic compounds. Acta Pharmacologica et Toxicologica, 31(4), 273–286.
2. Akerman, B., Hellberg, I. B., & Trossvik, C. (1988). Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiologica Scandinavica , 32 ( 7 ) , 5 7 1 – 5 7 8 . d o i : 1111/j.1399-6576.1988.tb02788.x.
3. A l b r i g h t , G . A . ( 1 9 7 9 ) . C a r d i a c a r r e s t f o l l o w i n g r e g i o n a l anesthesia with etidocaine or bupivacaine. Anesthesiology, 51(4), 285–287. doi:10.1097/00000542-197910000-00001.
4. Auroy, Y., Narchi, P., Messiah, A., Litt, L., Rouvier, B., & Samii, K. (1997). Serious complications related to regional anesthesia: results of prospective survey in Anesthesiology, 87(3), 479–486. doi: 10.1097/00000542-199709000-00005.
5. Badner, N. H., Reid, D., Sullivan, P., Ganapathy, S., Crosby, E. T., McKenna , & Lui, A. (1996). Continuous epidural infusion of ropivacaine for the prevention of postoperative pain after major orthopaedic surgery: a dose-finding study. Canadian Journal of Anaesthesia, 43(1), 17–22. doi: 10.1007/BF03015952.
6. Beilin, Y., Galea, , Zahn, J., & Bodian, C. A. (1999). Epidural ropivacaine for the initiation of labor epidural analgesia: a dose finding study. Anesthesia & Analgesia, 88(6), 1340–1345. doi: 10.1097/00000539-199906000-00027.
7. Benhamou, , Hamza, J., Eledjam, J. J., Dailland P., Palot, M., Seebacher, J., … Heeroma, K. (1997). Continuous extradural infusion of ropivacaine 2mg ml–1 for pain relief during labour. British Journal of Anaesthesia, 78(6), 748–750. doi: 10.1093/bja/78.6.748. 
8. Bertini, L., Tagariello, V., Mancini, S., Ciaschi A., Posteraro C. , Benedetto P., & Martini, O. (1999). 0.75% and 0.5% ropivacaine for axillary brachial plexus block: a clinical comparison with 0.5% bupivacaine. Regional Anesthesia & Pain Medicine, 24(6), 514–518. doi: 10.1016/s1098-7339(99)90041-x. 
9. Casati , & Putzu M. (2005). Bupivacaine, levobupivacaine and ropivacaine: are they clinically different? Best Practice & Research Clinical Anaesthesiology, 19(2), 247–268. doi:10.1016/j.bpa.2004.12.003.
10. Cascio, M. G., Gaiser, R. R., Camann, W. R., Venkateswaran, P., Hawkens, J., & McCarthy D. (1998). Comparative evaluation of four different infusion rates of ropivacaine (2 mg/ml) for epidural labor Regional Anesthesia & Pain Medicine, 23(6), 548–553. doi: 10.1016/s1098-7339(98)90079-7.
11. Cederholm, I., Evers, H., & Lofstrom, J. B. (1991). Effect of intradermal injection of saline or a local anaesthetic agent on skin blood flow: a methodological study in man. Acta Anaesthesiologica Scandinavica, 35(3), 208–215. doi: 1111/j.1399-6576.1991.tb03275.x.
12. Cederholm, I., Evers, H., & Lofstrom, J. B. (1992). Skin blood flow after intradermal injection of ropivacaine in various concentrations with and without epinephrine evaluated by laser Doppler flowmetry. Regional Anesthesia, 17(6), 322–328.
13. Cederholm, , Akerman, B., & Evers, H. (1994). Local analgesic and vascular effects of intradermal ropivacaine and bupivacaine in various concentrations with and without addition of adrenaline in man. Acta Anaesthesiologica Scandinavica, 38(4), 322–327. doi: 10.1111/j.1399-6576.1994.tb03901.x.
14. Clarkson, W., & Hondeghem, L. M. (1985). Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology, 62(4), 396–405.
15. Ekström, , & Gunnarsson, U. B. (1996). Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes. Drug Metabolism & Disposition, 24(9), 955–961.
16. F a c c e n d a , K . A . , & F i n u c a n e , B . T . ( 2 0 0 1 ) . C o m p l i c a t i o n s of regional anaesthesia: incidence and prevention. Drug Safety, 24(6), 413–442. doi:10.2165/00002018-200124060-00002.
17. Fanelli, , Casati, A., Beccaria, P., Aldegheri, G., Berti, M., Tarantino, F., & Torri, G. (1998). A double-blind comparison of ropivacaine, bupivacaine, and mepivacaine during sciatic and femoral nerve blockade. Anesthesia & Analgesia, 87(3), 597–600. doi: 10.1097/00000539-199809000-00019.
18. Graf, B. , Abraham, I., Eberbach, N., Kunst, G., Stowe, D., & Martin, E.(2002). Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties. Anesthesiology, 96(6), 1427–1434. doi: 10.1097/00000542-200206000-00023.
19. Groban, , Deal, D. D., Vernon, J. C., James, R. L., & Butterworth, J. (2001). Cardiac resuscitation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine in anesthetized dogs. Anesthesia & Analgesia, 92(1), 37–43. doi: 10.1097/00000539-200101000-00008.
20. Guinard, , Carpenter, R., Owens, B., & Nadir, B. (1991). Comparison between ropivacaine and bupivacaine after subcutaneous injection in pigs: cutaneous blood flow and surgical bleeding. Regional Anesthesia, 16(5), 268–271.
21. Hickey, R., Blanchard, J., Hoffman, J., Sjovall, J., & Ramamurthy, (1990). Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block. Canadian Journal of Anaesthesia, 37(8), 878–882. doi: 10.1007/BF03006624.
22. Horlocker, T. T. (1998). Peripheral nerve blocks: regional anesthesia for the new millennium. Regional Anesthesia & Pain Medicine, 23(3), 237–240. doi:10.1016/s1098-7339(98)90047-5.
23. Huang, , Pryor, M., Mather, L., & Veering, B. (1998). Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesthesia & Analgesia, 86(4), 797–804. doi: 10.1097/00000539-199804000-00023.
24. Jacob, B., Zippelius, T., Kloss, N., Benad, K., Schwerdt, C., Hoff, P., … Rohner, (2019). Local anesthetics’ toxicity toward human cultured chondrocytes: a comparative study between lidocaine, bupivacaine, and ropivacaine. Cartilage, 10(3), 364–369. doi: 10.1177/1947603518758436.
25. Johansson, , Glise, H., Hallerback, B., Dalman, P., & Kristoffersson, A. (1994). Preoperative local infiltration with ropivacaine for postoperative pain relief after cholecystectomy. Anesthesia & Analgesia, 78(2), 210–214. doi: 10.1213/00000539-199402000-00003.
26. J o s h i , G . P . , & W h i t e , P . F . ( 2 0 0 2 ) . M a n a g e m e n t o f a c u t e a n d postoperative pain. Current Opinion in Anaesthesiology, 14(4), 417–421. doi: 1097/00001503-200108000-00007.
27. Kopacz, J., Carpenter, R. L., & Mackey, D. C. (1989). Effect of ropivacaine on cutaneous capillary blood flow in pigs. Anesthesiology, 71(1), 69–74. doi: 10.1097/00000542-198907000-00013.
28. Lee, , Fagan, D., Lamont, M., Tucker, G., Halldin, M., & Scott, D. (1989). Disposition kinetics of ropivacaine in humans. Anesthesia & Analgesia, 69(3), 736–738.
29. Liang М., Chen , Zhu W., & Zhou D. (2020). Efficacy and safety of different doses of ropivacaine for laparoscopy-assisted infiltration analgesia in patients undergoing laparoscopic cholecystectomy. A prospective randomized control trial. Medicine (Baltimore), 99(46), 225–240. doi: 10.1097/MD.0000000000022540.
30. Litz, , Frank, M., Wagner, B., Koch, T., & Albrecht, D. (1999). Anaesthesiology & Intensive Medicine, 40, 423.
31. McClure, H. (1996). Ropivacaine. British Journal of Anaesthesia, 76(2), 300–307. doi: 10.1093/bja/76.2.300.
32. McGlade, D. P., Kalpokas, M. V., Mooney, P. H., Buckland, M. R., Vallipuram, S. K., Hendrata, M. V., & Torda, T.A. (1997). Comparison of 5% ropivacaine and 0.5% bupivacaine in lumbar epidural anaesthesia for lower limb orthopaedic surgery. Anaesthesia and Intensive Care, 25(3), 262–266. doi: 10.1177/0310057X9702500310.
33. McGlade, P., Kalpokas, M. V., Mooney, P. H., Chamley, D., Mark, A. H., & Torda, T. A. (1998). A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesthesia and Intensive Care, 26(5), 515–520. doi: 10.1177/0310057X9802600507. 
34. Muldoon, , Milligan, K., Quinn, P., Connolly, D. C., & Nilsson K. (1998). Comparison between extradural infusion of ropivacaine or bupivacaine for the prevention of postoperative pain after total knee arthroplasty. British Journal of Anaesthesia, 80(5), 680–681. doi: 10.1093/bja/80.5.680.
35. Nakamura, K., Toda, H., Kakuyama, M., Nishiwada, M., Yamamoto, M., Hatano, , & Mori, K. (1993). Direct vascular effect of ropivacaine in femoral artery and vein of the dog. Acta Anaesthesiologica Scandinavica, 37(3), 269–273. doi: 10.1111/j.1399-6576.1993.tb03714.x.
36. Nancarrow, C., Rutten, A., Runciman, W., Mather, L. E., Carapetis, R. J., McLean, F., & Hipkins, S. F. (1989). Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesthesia & Analgesia, 69(3), 276–283.
37. Oda, , Furuichi, K., Tanaka, K., Hiroi, T., Imaoka, S., Asada, A., … Funae, Y. (1995). Metabolism new local anesthetic, ropivacaine, by human hepatic cytochrome P450. Anaesthesiology, 82(1), 214–220. doi: 10.1097/00000542-199501000-00026.
38. Raeder, J. C., Drosdahl, S., Klaastad, O., Kvalsvik, O., Isaksen, , Stromskag, K. E., … Selander, D. (1999). Axillary brachial plexus block with ropivacaine 7.5 mg/ml: a comparative study with bupivacaine 5 mg/ml. Acta Anaesthesiologica Scandinavica, 43(8), 794–798. doi: 10.1034/j.1399-6576.1999.430802.x.
39. Rao, , Zhou, H., Pan, X., Chen, J., Wang, Y., Wang, Z., & Ding, Z. (2017). Ropivacaine wound infiltration: a fast-track approach in patients undergoing thoracotomy surgery. Journal of Surgical Research, 220, 379–384. doi: 10.1016/j.jss.2017.05.082.
40. Reiz, , & Nath, S. (1986). Cardiotoxicity of local anaesthetic agents. British Journal of Anaesthesia, 58(7), 736–746. doi: 10.1093/bja/58.7.736.
41. Ruetsch, Y., Fattinger, K., & Borgeat, A. (1999). Ropivacaine-induced convulsions and severe cardiac dysrhythmia after sciatic Anesthesiology, 90(6), 1784–1786. doi: 10.1097/00000542-199906000-00040.
42. Sia, A. T., & Chong, J. L. (1999). Epidural 2% ropivacaine for labour analgesia: parturient-controlled or continuous infusion? Anaesthesia and Intensive Care, 27(2), 154–158. doi: 10.1177/0310057X9902700204.
43. Sia, A. T., Ruban, P., Chong, J. L., & Wong, K. (1999). Motor blockade is reduced with ropivacaine 125% for parturient-controlled epidural analgesia during labour. Canadian Journal of Anaesthesia, 46(11), 1019–1023. doi: 10.1007/BF03013195.
44. Scott, D., Lee, A., Fagan, D., Bowler, G. , Bloomfield, P., & Lundh, R. (1989). Acute toxicity of ropivacaine compared with that of bupivacaine. Anesthesia & Analgesia, 69(5), 563–569.
45. Vanhoutte, F., Vereecke, J., Verbeke, N., & Carmeliet, E. (1991). Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guineapig papillary muscle. British Journal of Pharmacology, 103(1), 1275–1281. doi:10.1111/j.1476-5381.1991.tb12336.x.
46. Vladimirov, M., Nau, C., Mok, W., & Strichartz, G. (2000). Potency of bupivacaine stereoisomers tested in vitro and in vivo: biochemical, elec- trophysiological, and neurobehavioral Anesthesiology, 93(3), 744–755. doi: 10.1097/00000542-200009000-00024.
47. Voulgaropoulos, D., Johnson, , & Covino, B. (1990). Local Anesthetic Toxicity. Seminars in Anesthesia, 9, 8–15.
48. Whiteside, B., & Wildsmith, J. A. (2001). Developments in local anaesthetic drugs. British Journal of Anaesthesia, 87(1), 27–35. doi.org/10.1093/bja/87.1.27.
49. Wildsmith, A. (2000). Relative potencies of ropivacaine and bupivacaine. Anesthesiology, 92(1), 283–284. doi: 10.1097/00000542-200001000-00050.
50. Writer, W. D., Stienstra, R., Eddleston, J. M., Gatt, S. P., Griffin, R., Gutsche, B., … Selander, D. (1998). Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta- analysis. British Journal of Anaesthesia, 81(5), 713–717. doi: 10.1093/bja/81.5.713.
51. Zink, W., & Graf, B. M. (2004). Benefit-risk assessment of ropivacaine in the мanagement of рostoperative рain. Drug Safety, 27(14), 1093–1114. doi:10.2165/00002018-200427140-00003.
52. Zink, , Seif, C., Bohl, J., Hacke, N., Braun, P., Sinner, B., … Graf, B. (2003). The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades. Anesthesia & Analgesia, 97(4), 1173–1179. doi:10.1213/01.ANE.0000080610.14265.C8.